bioRxiv/medRxiv TRiP Review Activity

438 Reviews — All Partners — Cancer Biology

Most recent first Previous |  Page 24: Articles 231-240  | Next

MYC disrupts transcriptional and metabolic circadian oscillations in cancer and promotes enhanced biosynthesis
DeRollo, R. E., Cazarin, J., Ahmad Shahidan, S. N. A. B., Burchett, J. B., Mwangi, D., Krishnaiah, S., Hsieh, A. L., Walton, Z. E., Brooks, R., Mello, S. S., Weljie, A. M., Dang, C. V., Altman, B. J.
10.1101/2023.01.03.522637 — Posted: 2023-01-03 — Discussion: 2023-08-25  Review Commons
Identifying targetable metabolic dependencies across colorectal cancer progression
Legge, D. N., Holt, A. K., Bull, C. J., Collard, T. J., Kollareddy, M., Bellamy, J., Groves, S., Ma, E. H., Hazelwood, E., Qualtrough, D., Amulic, B., Malik, K. N., Williams, A. C., Jones, N., Vincent, E. E.
10.1101/2022.03.23.485483 — Posted: 2022-03-23 — Discussion: 2023-08-23  Review Commons
Complementary CRISPR screen highlights the contrasting role of membrane-bound and soluble ICAM-1 in regulating antigen specific tumor cell killing by cytotoxic T cells
Mattes, A.-K., Puig Gamez, M., Martin, E., Boryn, L., Baskaran, P., Huber, H. J., Schuler, M., Park, J. E., Swee, L. K.
10.1101/2022.08.26.505456 — Posted: 2022-08-27 — Discussion: 2023-08-20  eLife
The BRD4S-LOXL2-MED1 interaction at the forefront of cell cycle transcriptional control in triple-negative breast cancer
Pascual-Reguant, L., Tian, T. V., Datta, D., Cianferoni, D., Kourtis, S., Ganez Zapater, A., Cannata, C., Serra Camprubi, Q., Espinar, L., Guirola, M., Querol, J., Miro Canturri, A., Arribas, J., Serrano, L., Peiro, S., Sdelci, S.
10.1101/2022.05.27.493725 — Posted: 2022-05-28 — Discussion: 2023-08-03  Review Commons
ATR inhibition augments the efficacy of lurbinectedin in small cell lung cancer
Schultz, C. W., Zhang, Y., Elmeskini, R., Zimmermann, A., Fu, H., Murai, Y., Wangsa, D., Kumar, S., Takahashi, N., Atkinson, D., Saha, L. K., Lee, C.-F., Elenbaas, B., Desai, P., Sebastian, R., Ried, T., Aladjem, M., Zenke, F. T., Weaver, Z., Pommier, Y., Thomas, A.
10.1101/2022.12.16.520783 — Posted: 2022-12-19 — Discussion: 2023-08-02  EMBO Press
ONC201/TIC10 enhances durability of mTOR inhibitor everolimus in metastatic ER+ breast cancer
Farmaki, E., Nath, A., Emond, R., Karimi, K. L., Grolmusz, V. K., Cosgrove, P. A., Bild, A. H.
10.1101/2022.12.27.522019 — Posted: 2022-12-27 — Discussion: 2023-07-19  eLife
RAF autoinhibition and 14-3-3 proteins promote paradoxical activation
Mendiratta, G., McFall, T., Stites, E. C.
10.1101/849489 — Posted: 2019-11-20 — Discussion: 2023-07-19  eLife
Isoform-specific Disruption of the TP73 Gene Reveals a Critical Role for TAp73gamma in Tumorigenesis via Leptin
Kong, X., Yan, W., Sun, W., Zhang, Y., Yang, H. J., Chen, M., Chen, H., de Vere White, R. W., Zhang, J., Chen, X.
10.1101/2022.08.07.503085 — Posted: 2022-08-07 — Discussion: 2023-07-16  eLife
Treatment with Tumor-Treating Fields (TTFields) Suppresses Intercellular Tunneling Nanotube Formation In Vitro and Upregulates Immuno-Oncologic Biomarkers In Vivo in Malignant Mesothelioma
Sarkari, A., Korenfeld, S., Ladner, K., Wong, P., Padmanabhan, S., Vogel, R. I., Sherer, L., Courtemanche, N., Steer, C., Wainer-Satsir, K., Lou, E.
10.1101/2022.12.29.522223 — Posted: 2022-12-30 — Discussion: 2023-07-09  eLife
Vitamin D induces SIRT1 activation through K610 deacetylation in colon cancer
Garcia-Martinez, J. M., Chocarro-Calvo, A., Martinez-Useros, J., Fernandez-Acenero, M. J., Fiuza, M. C., Caceres-Rentero, J., De la Vieja, A., Barbachano, A., Munoz, A., Larriba, M. J., Garcia Jimenez, C.
10.1101/2023.02.22.529558 — Posted: 2023-02-24 — Discussion: 2023-07-06  eLife

Evaluation Sources